Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPAS1 | Q99814 | 16/20 | 0.43 |
| ▸ | VEGFA | P15692 | 3/20 | 0.42 |
| ▸ | CCR2 | P41597 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18036960 | 0.76 | EPAS1 (0.52) | EPAS1VEGFACCR2MEN1KMT2A | |
| SCHEMBL16555935 | 0.72 | EPAS1 (0.54) | EPAS1VEGFA | |
| SCHEMBL6721549 | 0.70 | MEN1 (0.39) | EPAS1VEGFAALDH1A1MEN1KMT2A | |
| SCHEMBL30165578 | 0.70 | HSD11B1 (0.51) | ALDH1A1MEN1KMT2A | |
| SCHEMBL4433417 | 0.70 | HSD11B1 (0.51) | ALDH1A1MEN1KMT2A | |
| SCHEMBL6929900 | 0.69 | CA2 (0.44) | CCR2ALDH1A1MEN1KMT2ACA1 | |
| SCHEMBL11420060 | 0.68 | HSD17B10 (0.43) | EPAS1VEGFAMEN1KMT2A | |
| SCHEMBL2788764 | 0.68 | HSD11B1 (0.51) | EPAS1VEGFAALDH1A1CA1CA2 | |
| SCHEMBL16555663 | 0.67 | EPAS1 (0.61) | EPAS1VEGFA | |
| SCHEMBL12074950 | 0.65 | DRD2 (0.33) | EPAS1VEGFACA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2368892-B1 | NOVEL COMPOUND, PROCESS FOR PRODUCING THE COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC SEMICONDUCTOR DEVICE | UNIV HIROSHIMA (JP) | 2014-12-03 | — | — | EP | disclosed |
| US-8816100-B2 | Compound, method of producing the compound, organic semiconductor material and organic semiconductor device | HIROSHIMA UNIVERSITY (JP) | 2014-08-26 | — | — | US | disclosed |
| US-20140051865-A1 | DESCRIPTION NOVEL COMPUND, METHOD OF PRODUCING THE COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC SEMICONDUCTOR DEVICE | HIROSHIMA UNIVERSITY (JP) | 2014-02-20 | — | — | US | disclosed |
| EP-2368892-A1 | NOVEL COMPOUND, PROCESS FOR PRODUCING THE COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC SEMICONDUCTOR DEVICE | Hiroshima University (JP) | 2011-09-28 | — | — | EP | disclosed |
| US-20110224445-A1 | Novel Compound, Method of Producing the Compound, Organic Semiconductor Material and Organic Semiconductor Device | HIROSHIMA UNIVERSITY (JP) | 2011-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224445-A1 | Novel Compound, Method of Producing the Compound, Organic Semiconductor Material and Organic Semiconductor Device | TST, SCLY, SELENOI | EPAS1 4335/4885VEGFA 3568/4885CCR2 918/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.